In an earlier study, Imaeda and colleagues showed that while peritoneal injection of IL-33 could accelerate the disease, the treatment also prevented the depletion of goblet cells in the DSS-induced colitis, possibly through inhibition of the Notch signalling [46]. The gene discussed is IL33; the disease is colitis.